Clinical trial · Observational
Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
NCT00526578CI-TRIAL-00042607unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this research study is to investigate the role of genes that may point to a higher risk of developing pancreatic cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Questionnaire
- description
- Pancreatic cancer patients or family member.
- interventionNames
- Behavioral: Questionnaire
Primary outcomes (1)
- measure
- Identification of susceptibility genes in high risk familial pancreatic cancer (FPC) pedigrees using cutting-edge genetic analysis methods
- timeFrame
- 8 Years
- description
- Data collection from patient response to 30-40 minute questionnaire and blood test.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1\) An effected or uneffected member of a family, age 18 or older, that has two or more reported pancreatic cancers in the family. Exclusion Criteria: 1. Cases under age 18. 2. Relatives of pancreatic cancer cases under age 18.
References
Publications (0)
Data not yet available
No reference posted for this study.